The Effect of Taking Resveratrol Supplement During Heart Rehabilitation Exercises on the Lipid Profile of Patients Undergoing Coronary Artery Bypass Graft Surgery: Randomized Clinical Trial
Authors
- Javad Almasi 1 1- Dept. of Physical Education, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
-
Kamal Azizbeigi2
2- Dept. of Physical Education, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
http://orcid.org/0000-0002-5963-2323
- Khalid Mohammad Zade Salamat 2
- Behshad Naghsh Tabrizi 3 3- Cardiovascular Specialist, Hamadan University of Medical Sciences, Hamadan, Iran.
- Mohammad Ali Azarbaijani 4 4- Dept. of Sport Physiology, Tehran Central Branch, Islamic Azad University, Tehran, Iran.
DOI:
https://doi.org/10.22100/jkh.v13i2.1863Keywords:
Oxidative stress, Resveratrol, Exercise therapy, LipoproteinsAbstract
Introduction: Oxidative stress is an important issue in the reduction of recovery rate of bypass patients. Antioxidant supplements have a pivotal role on modifying oxidative stress and inflammation in these patients. In the current study attempts have been made to investigate the synergistic effects of taking Resveratrol supplement with selective exercise recovery training on the lipid profile of patients.
Methods: In a randomized clinical trial study, among 85 patients referred to the Farshchian Cardiovascular Subspecialty University Hospital, who undergoing coronary artery bypass graft surgery and had not chest angina symptom during exercise test, 40 voluntary subjects were entered into the study and randomly assigned to the four groups: Resveratrol supplement consumption (RSC; n=10), Resveratrol supplement with rehabilitation (RSR; n=10), rehabilitation exercise training (RET; n=10), and control (Con; n=10). The selective sports exercises program lasted for eight weeks. Treatment sessions were organized three secessions for every other day during eight weeks, while supplement group subjects received 400 mg/day resveratrol. Blood sample was taken before exercise training and after 48 hours. Very low density lipoprotein (VLDL), Low density lipoprotein (LDL), triglyceride (TG), and cholesterol (CHOL) concentration were measured. Analysis of covariance was used for data analyzing and 0.05 was considered as a level of significance
Results: Results showed that TG and CHOL concentration improved in the RET, RSR, and RSC than control (p≤0.05), while there was no significant difference between RET, RSR, and RSC (P˃0.05). There is a significant LDL change in RET than control (P=0.046). Also HDL contrarian in RSR was greater than control (P=0.007).
Conclusion: It can be said that combined reasveratrol and selective exercise rehabilitation training could improve some lipid profiles and it is more effective than just exercise training rehabilitation and Resveratrol supplement on lipid profiles.
References
World health organization. Cardiovascular disease mediacenterel, 311-171.
Mozafari A, Hejazi SF, Baharvand A, Marvi M, Olomi Doran V, Mohebi S, Gharebeigloo M. The effect of cardiac rehabilitation on the results of 6-minute walk test in post angioplasty cardiac patients referred to Shahid Beheshti Hospital in Qom city, Iran. Qom Univ Med Sci J 2015;9:41-7.[Persian].
Zordoky BN, Robertson IM, Dyck JR. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 2015; 1852:1155-77. doi: 10.1016/j.bbadis.2014.10.016
Shabani R, Mozaffari M, Heidari Moghadam R, Shirmohamadi T, Vafaee R. Effect of cardiac rehabilitation program on quality of life in patients with myocardial infarction in Hamadan. Research in Medicine 2013;36:117-22.
Wang H, Yang Y, Qian HY, Zhang Q, Xu H, Li JJ. Resveratrol in cardiovascular disease: what is known from current research? Heart Fail Rev 2012;17:437-48. doi: 10.1007/s10741-011-9260-4
Franklin BA, Whaley MH, Howley ET, Balady GJ, ACSM. ACSM's guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins, 2006; 112-119.
Petrovski G, Gurusamy N, Das DK. Resveratrol in cardiovascular health and disease. Ann N Y Acad Sci 2011;1215:22-33. doi: 10.1111/j.1749-6632.2010.05843.x
Liu X, Tian J, Bai Q, Ashraf MA, Sarfraz M, Zhao B. The effect and action mechanism of resveratrol on the vascular endothelial cell by high glucose treatment. Saudi J Biol Sci 2016; 23:S16-21. doi: 10.1016/j.sjbs.2015.06.021
Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919-23.
Adams J, Cline M, Reed M, Masters A, Ehlke K, Hartman J. Importance of resistance training for patients after a cardiac event. Proc (Bayl Univ Med Cent) 2006;19:246-8.
Hong SW, Jung KH, Zheng HM, Lee HS, Suh JK, Park IS, et al. The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats. Arch Pharm Res 2010;33:601-9. doi: 10.1007/s12272-010-0415-y
Faghihzadeh F, Adibi P, Hekmatdoost A. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study. Br J Nutr 2015;14;114:796-803. doi: 10.1017/S0007114515002433
Van der Made SM, Plat J, Mensink RP. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One 2015;19:10:e0118393. doi: 10.1371/journal.pone.0118393
Zortea K , Franco VC, Francesconi LP , Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Resveratrol supplementation in schizophrenic patients: a randomized clinical trial evaluating serum glucose and cardiovascular risk factors. Nutrients 2016;8:73. doi: 10.3390/nu8020073
Fullerton MD, Steinberg GR. SIRT1 takes a backseat to AMPK in the regulation of insulin sensitivity by resveratrol. Diabetes 2010;59:551-3. doi: 10.2337/db09-1732
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
